ScholarLens Back to search
2018•Human PathologyOpen access

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors

Angela S. Y. Chou, Malinda Itchins, Philip R. de Reuver, Jennifer Arena, Adele Clarkson, Amy Sheen, Loretta Sioson, Veronica Ka-Yan Cheung, Aurel A. Perren, Christopher Bahdah Nahm, Anubhav Mittal, Jaswinder Singh Samra, Marina Pajic, Anthony James Gill

Open full text 56 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 56 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: ATRX, Death-associated protein 6, Biology, Cancer research, Neuroendocrine tumors, Telomere, MEN1, Internal medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors — Research Paper | ScholarLens